Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Rheumatoid Arthritis Phase 4 Clinical Trial Data Recently Presented at the Annual European Congress of Rheumatology (EULAR 2018)
Multiple Sclerosis Relapse Observational Registry Data Recently Presented at the 2018 Annual Meeting of the Consortium of Mu... Biopharmaceuticals Mallinckrodt, H.P. Acthar Gel, Rheumatoid Arthritis, Multiple Sclerosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Arthritis | Clinical Trials | Multiple Sclerosis | Politics | Rheumatoid Arthritis | Rheumatology | Study